page 2 - The sanofi-aventis Group profile
THE SANOFI-AVENTIS GROUP PROFILE
- • A global healthcare leader
- • No. 1 in emerging markets(1) with a broad and balanced presence
- • Approximately 105,000 employees in 110 countries
- • A diversified offering of medicines, consumer healthcare products and generics
- • A world leader in human vaccines
- • A global leader in animal health
- • 2009 net sales: €29.3 billion; growth of 6.3% (2)
- • 33 partnerships and acquisitions in 2009
Sanofi-aventis’ ambition is to become a diversified global healthcare leader, focused on patients’ needs.
Group strategy is based on three key principles in order to deliver long-term sustainable growth:
- • increasing innovation in Research & Development;
- • seizing external growth opportunities;
- • adapting Group structures for future challenges.
Sanofi-aventis has core strengths in the field of healthcare with five growth platforms: emerging markets, human vaccines, consumer healthcare, diabetes treatment and innovative products.
(1) World excluding the United States, Canada, Western Europe (France, Germany, United Kingdom, Italy, Spain, Greece, Cyprus, Malta, Belgium, Luxembourg, Sweden, Portugal, the Netherlands, Austria, Switzerland, Ireland, Finland, Norway, Iceland, Denmark), Japan, Australia and New Zealand.
(2) Compared with 2008 on a reported basis.